|
CASKIN2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63269398001376E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.27984298106776E-12 |
| Normal-vs-Stage2 |
3.32100003053171E-09 |
| Normal-vs-Stage3 |
3.31350002991115E-09 |
| Normal-vs-Stage4 |
7.63950000000069E-05 |
| Stage1-vs-Stage2 |
1.518630E-01 |
| Stage1-vs-Stage3 |
3.934400E-01 |
| Stage1-vs-Stage4 |
8.028000E-01 |
| Stage2-vs-Stage3 |
5.530200E-01 |
| Stage2-vs-Stage4 |
5.016400E-01 |
| Stage3-vs-Stage4 |
7.968000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.64113167500091E-12 |
| Normal-vs-AfricanAmerican |
1.96260008245019E-10 |
| Normal-vs-Asian |
1.192580E-04 |
| Caucasian-vs-AfricanAmerican |
4.319000E-01 |
| Caucasian-vs-Asian |
4.978800E-01 |
| AfricanAmerican-vs-Asian |
3.199400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.86484161446288E-12 |
| Normal-vs-Female |
3.19810844473523E-12 |
| Male-vs-Female |
5.674600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.19779980273438E-10 |
| Normal-vs-Extreme_Weight |
5.29549737393609E-11 |
| Normal-vs-Obese |
5.20040011053879E-10 |
| Normal-vs-Extreme_Obese |
2.157800E-03 |
| Normal_Weight-vs-Extreme_Weight |
5.524000E-01 |
| Normal_Weight-vs-Obese |
3.168600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.710570E-01 |
| Extreme_Weight-vs-Obese |
6.292600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.710400E-01 |
| Obese-vs-Extreme_Obese |
3.752800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.39089999999731E-05 |
| Normal-vs-Age(41-60Yrs) |
6.12400130606261E-11 |
| Normal-vs-Age(61-80Yrs) |
1.97619698383278E-14 |
| Normal-vs-Age(81-100Yrs) |
3.45060002793218E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.199800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.043030E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.022600E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.048400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.517600E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.021600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.48539974659445E-10 |
| Normal-VS-Type2 PRCC |
<1E-12 |
| Normal-VS-KIRP CIMP |
1.436740E-04 |
| Normal-VS-Unclassified PRCC |
8.23100000379995E-08 |
| Type1 PRCC-VS-Type2 PRCC |
2.36270003561856E-09 |
| Type1 PRCC-VS-KIRP CIMP |
6.559600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.059800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.344000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.150300E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
8.821600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.70574665503409E-12 |
| Normal-vs-N1 |
3.55280005415182E-09 |
| Normal-vs-N2 |
1.141980E-02 |
| N0-vs-N1 |
7.293400E-01 |
| N0-vs-N2 |
3.831400E-01 |
| N1-vs-N2 |
4.480200E-01 |
|
|
